$2125 | SAVE $375 | Single User
$4250 | SAVE $750 | Site License
$6375 | SAVE $1,125 | Enterprise License

Ulcerative Colitis Global Clinical Trials Review, H2, 2016

Ulcerative Colitis Global Clinical Trials Review, H2, 2016
[Lowest Price Guaranteed: $2,125]

Published by Global Data: 28 Sep 2016 | 27440 | In Stock
Related Topics: Clinical Trials , Ulcerative Colitis

Introduction

Ulcerative Colitis Global Clinical Trials Review, H2, 2016

Summary

GlobalData's clinical trial report, “Ulcerative Colitis Global Clinical Trials Review, H2, 2016" provides an overview of Ulcerative Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on Ulcerative Colitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Ulcerative Colitis Global Clinical Trials Review, H2, 2016

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9

    Top Five Countries Contributing to Clinical Trials in Europe 10

    Top Countries Contributing to Clinical Trials in North America 11

    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12

    Top Five Countries Contributing to Clinical Trials in Central and South America 13

    Clinical Trials by G7 Countries: Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials 14

    Clinical Trials by Phase in G7 Countries 15

    Clinical Trials in G7 Countries by Trial Status 16

    Clinical Trials by E7 Countries: Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials 17

    Clinical Trials by Phase in E7 Countries 18

    Clinical Trials in E7 Countries by Trial Status 19

    Clinical Trials by Phase 20

    In Progress Trials by Phase 21

    Clinical Trials by Trial Status 22

    Clinical Trials by End Point Status 23

    Subjects Recruited Over a Period of Time 24

    Clinical Trials by Sponsor Type 25

    Prominent Sponsors 26

    Top Companies Participating in Ulcerative Colitis Therapeutics Clinical Trials 27

    Prominent Drugs 29

    Latest Clinical Trials News on Ulcerative Colitis 30

    Sep 21, 2016: Gilead Terminates Phase 2/3 Study of GS-5745 in Patients With Ulcerative Colitis 30

    Sep 16, 2016: Favorable Benefit: Risk Profile for Vedolizumab as Induction and Maintenance Therapy in TNF-Naïve or TNF-Failure Patients with Moderately to Severely Active Ulcerative Colitis Published in Clinical Gastroenterology and Hepatology 30

    Aug 22, 2016: Lycera Announces Initiation of Phase 2 Clinical Trial of LYC-30937-EC in Patients with Ulcerative Colitis 31

    Jul 28, 2016: Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ (Tofacitinib Citrate) in Ulcerative Colitis 32

    Jul 13, 2016: InDex Pharmaceuticals publishes results from COLLECT study 33

    Clinical Trial Profile Snapshots 34

    Appendix 494

    Abbreviations 494

    Definitions 494

    Research Methodology 495

    Secondary Research 495

    About GlobalData 496

    Contact Us 496

    Disclaimer 496

    Source 497

List Of Tables
in Ulcerative Colitis Global Clinical Trials Review, H2, 2016

List of Tables

Ulcerative Colitis Therapeutics, Global, Clinical Trials by Region, 2016* 6

Ulcerative Colitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Ulcerative Colitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9

Ulcerative Colitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10

Ulcerative Colitis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11

Ulcerative Colitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12

Ulcerative Colitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13

Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 14

Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 17

Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18

Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19

Ulcerative Colitis Therapeutics, Global, Clinical Trials by Phase, 2016* 20

Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21

Ulcerative Colitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Ulcerative Colitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Ulcerative Colitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25

Ulcerative Colitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Ulcerative Colitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28

Ulcerative Colitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List Of Figures, Charts and Diagrams
in Ulcerative Colitis Global Clinical Trials Review, H2, 2016

List of Figures

Ulcerative Colitis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

Ulcerative Colitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

Ulcerative Colitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9

Ulcerative Colitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10

Ulcerative Colitis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11

Ulcerative Colitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12

Ulcerative Colitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13

Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 14

Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15

Ulcerative Colitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16

Proportion of Ulcerative Colitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 17

Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18

Ulcerative Colitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19

Ulcerative Colitis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20

Ulcerative Colitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21

Ulcerative Colitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22

Ulcerative Colitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23

Ulcerative Colitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24

Ulcerative Colitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25

Ulcerative Colitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26

Ulcerative Colitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27

Ulcerative Colitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

GlobalData Methodology 495

Additional Details

Publisher

Global Data

Publisher Information

Reference

27440 | GDHC3742CTIDB

Number of Pages

497

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Ulcerative Colitis - Pipeline Review, H1 2017
Ulcerative Colitis - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical an...
09 May 2017 by Global Markets Direct USD $1,700 (normally
USD $2,000)
More Info
SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2017
The Global Ulcerative Colitis Partnering Terms and Agreements since 2010 report provides understandi...
01 Apr 2017 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2017
The Global Ulcerative Colitis Partnering Terms and Agreements since 2010 report provides understandi...
01 Feb 2017 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Ulcerative Colitis: KOL Insight
Are UC biosimilars a real or perceived threat to branded drugs?Ulcerative colitis (UC) treatment is ...
01 Sep 2016 by FirstWord Pharma USD $6,715 (normally
USD $7,900)
More Info
SAVE 15% today! Adalimumab Market Analysis: by Applications (Rheumatoid Arthritis, Psoriasis, Crohn’s Disease, Ulcerative Colitis, and Others) and Geography – Forecast 2016-2021
Adalimumab, which is a patent product of the Abott Biotechnology Ltd., is a medication used for trea...
11 Mar 2016 by USD $5,250 (normally
USD $6,176)
More Info
SAVE 15% today! Ulcerative Colitis: Update Bulletin [Feb 2016]
IntroductionGain new KOL insights on the latest events happening in Ulcerative Colitis. Topics cover...
01 Feb 2016 by FirstWord Pharma USD $846 (normally
USD $995)
More Info
SAVE 15% today! Ulcerative Colitis: KOL Insight
Introductionipeline drugs are poised to reshape the way doctors treat ulcerative colitis (UC). But w...
01 Dec 2015 by FirstWord Pharma USD $6,715 (normally
USD $7,900)
More Info
SAVE 15% today! Ulcerative Colitis: KOL Insight
IntroductionThe Ulcerative Colitis (UC) treatment market is already undergoing radical change as new...
03 Dec 2014 by FirstWord Pharma USD $6,715 (normally
USD $7,900)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Ulcerative Colitis Global Clinical Trials Review, H2, 2016 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...